Mulpleta (Lusutrombopag)

Mulpleta (lusutrombopag) is a thrombopoietin receptor agonist used for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

Recommended Dosage:
The recommended dosage of Lusutrombopag is 3 mg taken orally once daily with or without food for 7 days. In the case of a missed dose, patients should take the missed dose as quickly as possible on the same day and return to the normal schedule the following day.
Lusutrombopag has been investigated only as a single 7-day once daily dosing regimen in clinical trials in patients with chronic liver disease. This medicine should not be administered to patients with chronic liver disease in an attempt to normalize platelet counts.

• Treatment with Lusutrombopag 3 mg may be responsible for increasing the risk of blood clots. Watch for symptoms like chest pain, sudden leg pain, or shortness of breath. Patients with liver disease are particularly at risk. Use this medicine cautiously in those with a known history of clotting or thrombosis.
• This therapeutic drug should be used during pregnancy only if clearly required. There’s limited data about its effects on unborn babies. Pregnant women should discuss with their healthcare provider (HCP) about potential risks as well as benefits before initiating treatment with this medicine.
• It is not known if this medicine passes into human breast milk. Breastfeeding mothers must consult their healthcare provider (HCP). A decision should be made to either stop the treatment or stop breastfeeding, depending on what is most beneficial for the mother and what the potential risk is to the infant.
• Lusutrombopag has not been evaluated in children. Its safety and effectiveness in patients aged under 18 years are not established. Clinicians should avoid prescribing this treatment to pediatric patients unless no alternative options are available and the benefits clearly outweigh the risks.
• Therapeutic effects of Lusutrombopag in patients 65 and older must be monitored attentively, as they may be more susceptible to the drug’s effects. While routine dose adjustments are not necessary, this age group should be monitored more closely, especially in terms of overall liver function and signs of possible clotting complications.

What documents are required to import MULPLETA to India?

MULPLETA (lusutrombopag) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is MULPLETA available in India?

MULPLETA (lusutrombopag tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Mulpleta in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

MULPLETA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of MULPLETA (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Mulpleta 3 mg Tablets price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source MULPLETA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Mulpleta®?

Lusutrombopag is the Generic Name for the trade name drug Mulpleta®.

What is the Manufacturer's Name of Mulpleta®?

Mulpleta® is manufactured by Shionogi Inc.

Is Mulpleta approved by the FDA?

Yes, Mulpleta is approved by the FDA. Date of first approval: July 31, 2018.

What is the dosage and form of Mulpleta® supplied?

Mulpleta is supplied in Tablets: 3 mg of lusutrombopag for oral use. It is designed to increase platelet counts in patients with chronic liver disease.

What are the most common side effects of Mulpleta® 3 mg Tablets?

The most commonly reported side effect of Mulpleta® 3 mg oral tablet is headache.

How much does Mulpleta® 3 mg Tablet cost in India?

Mulpleta® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Prices of Mulpleta Tablets may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Mulpleta 3 mg cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork.in.

Can Mulpleta® 3 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Mulpleta® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Mulpleta® Tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Mulpleta® 3 mg Tablets online in India?

Yes, one can buy Mulpleta 3 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Mulpleta® Tablets through legal channels.

What are the storage conditions of Mulpleta® 3 mg Tablets?

Store the oral tablets of lusutrombopag in the original package at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).